老年患者下呼吸道感染肺炎克雷伯菌检测及耐药性特点研究
2020-10-13陈龙


[摘要] 目的 探讨老年患者下呼吸道感染肺炎克雷伯菌检测及耐药性特点。方法 方便选取2016年1月—2018年12月到该院进行就诊的下呼吸道感染的4 035例老年患者作为研究对象,利用VITEK-2细菌鉴定药敏分析仪和K-B药敏纸片法对从中分离出的247株肺炎克雷伯菌,进行检测和观察对20种抗生素药物的耐药率情况。 结果 经实验室检测可知,一共检出感染病原菌1 452株,主要包括真菌、革兰阳性菌与革兰阴性菌,其中真菌主要是白色假丝酵母菌;革兰阳性菌主要是金黄色葡萄球菌;革兰阴性菌主要包括肺炎克雷伯菌、大肠埃希菌、鲍曼不动杆菌、铜绿假单胞菌、嗜麦芽寡养单胞菌、及其他革兰阴性菌。在对肺炎克雷伯菌的20种抗生素药敏实验中,氨苄西林、头孢唑啉、氨苄西林舒巴坦等药物的耐药率排在前3位,分别为100.00%、41.30%与34.80%,其余分别为哌拉西林他唑巴坦、头孢替坦、头孢他啶、头孢曲松、头孢吡肟、氨曲南、厄他培南、亚胺培南、阿米卡星、庆大霉素、妥布霉素、环丙沙星、左氧氟沙星、呋喃妥因、复方磺胺甲恶唑、美罗培南、头孢哌酮舒巴坦等。 结论 老年患者下呼吸道感染主包括真菌、革兰阳性菌与革兰阴性菌,其中主要病原菌是肺炎克雷伯菌;在治疗过程中,避免为患者使用氨苄西林、头孢唑啉、氨苄西林舒巴坦等药物,同时需要依据患者的检测结果为其选用适宜的抗菌药物。
[关键词] 下呼吸道感染;肺炎克雷伯菌;耐药性
[中图分类号] R56 [文獻标识码] A [文章编号] 1674-0742(2020)08(a)-0190-03
Detection and Drug Resistance of Klebsiella Pneumoniae in Elderly Patients with Lower Respiratory Tract Infection
CHEN Long
Department of laboratory, Sanming First Hospital Affiliated to Fujian Medical University, Sanming, Fujian Province, 3650000 China
[Abstract] Objective To explore the detection and drug resistance of Klebsiella pneumoniae in elderly patients with lower respiratory tract infection. Methods Convenient select 4 035 elderly patients with lower respiratory tract infection who came to the hospital from January 2016 to December 2018 were studied. 247 strains of Klebsiella pneumoniae isolated from them were detected by Vitek-2 bacterial identification drug sensitivity analyzer and K-B drug sensitivity disk method, and the drug resistance rate of 20 antibiotics was observed. Results A total of 1 452 strains of pathogenic bacteria were detected in the laboratory, including fungi, Gram-positive bacteria and Gram-negative bacteria, of which fungi were mainly Candida albicans, Gram-positive bacteria were mainly Staphylococcus aureus, Gram-negative bacteria were mainly Klebsiella pneumoniae, Escherichia coli, Acinetobacter baumannii, Pseudomonas aeruginosa, oligotrophic maltophilia and other gram-negative bacteria. Among the 20 antibiotic susceptibility tests to Klebsiella pneumoniae, ampicillin, cefazolin and ampicillin sulbactam were the top three drugs, which were 100.00%, 41.30% and 34.80% respectively, the others were piperacillin tazobactam, cefotetan, ceftazidime, ceftriaxone, cefepime, aztreonam, ertapenem, imipenem, amikacin and Qingda Mycomycin, tobramycin, ciprofloxacin, levofloxacin, furantoin, compound sulfamethoxazole, meropenem, cefoperazone sulbactam, etc. Conclusion The lower respiratory tract infection of elderly patients mainly includes fungi, Gram-positive bacteria and Gram-negative bacteria, among which the main pathogen is Klebsiella pneumoniae. In the treatment process, we should avoid using ampicillin, cefazolin, ampicillin sulbactam and other drugs for the patients, and at the same time, we need to select the appropriate antibiotics according to the test results of the patients.
[Key words] Lower respiratory tract infection; Klebsiella pneumoniae; Drug resistance
对于老年群体而言,由于其各项机体机能较弱,因而使得免疫力不断降低,导致下呼吸道感染是一种十分常见的临床疾病,通过实验室检测可知,其重要的感染病菌为肺炎克雷伯菌,因此需要予以良好的治疗[1]。……
